ISPE Highlights
Pharmaceutical Engineering Magazine
Highlights From ISPE Knowledge Network
- Preventing Resin-Floor Failures in Regulated Facilities: A Practical Substrate and Installation Checklist
- When a Plan Comes Together: How Architects Improve Master Planning
- Bayer AG's SOLIDA-1 FOYA Category Award-Winning Facility
- Annex 1 and Global Harmonization on Aseptic Filling: Insights from the 2026 ISPE Aseptic Conference Regulatory Panel
- How Pharma 4.0™ Supports Inspection-Ready Compliance at the 2026 ISPE Pharma 4.0™ and Biopharma Conference
- Will EU GMP Annex 22 Include Grandfathering for Legacy Artificial Intelligence Systems? Lessons from 21 CFR Part 11
- Driving ISPE's Strategic Vision: Innovation Through Shared Ideas
- Insights from the 2026 ISPE Annual Meeting & Expo Chairs
- Manufacturing the Medicines of Tomorrow: Scaling Innovation for Patient Impact
- An Evening with the ISPE Italy Affiliate: Community and Purpose During CPHI in Milan
- Communication as Technical Infrastructure in Pharmaceutical Manufacturing
- From Digital Transformation to Human-Centric Manufacturing: Designing Collaborative Workspaces for the Future of Pharma
- An Evening with the ISPE Italy Affiliate: Community and Purpose During CPHI in Milan
- From Checklist to Culture: Uniting Quality Risk Management (QRM) and Knowledge Management (KM) for Supply Reliability: A Joint Discussion on QRM and KM
- Antibody-Drug Conjugate (ADC) Cleaning Validation: How to Evaluate Degradation, Select Analytical Methods, and Reduce Validation Risk
- From Digital Transformation to Human-Centric Manufacturing: Designing Collaborative Workspaces for the Future of Pharma
- From Checklist to Culture: Uniting Quality Risk Management (QRM) and Knowledge Management (KM) for Supply Reliability: A Joint Discussion on QRM and KM
- The Second Question
- Five Questions Quality and Regulatory Teams Should Ask Before Treating a Regulatory Update as “Actionable”
- From Cloud Migration to Validated Platform Engineering: A Practical Path for GxP Systems
- Manufacturing the Medicines of Tomorrow: Scaling Innovation for Patient Impact
- Scope 3 Sustainability in the Pharmaceutical Industry: Reality or Aspiration?
- Automated Cross-Grade Material Transfer – A Perspective – Part II
- Formulation Choices in Cannabidiol Drug Development Beyond Dispersion
- Preventing Resin-Floor Failures in Regulated Facilities: A Practical Substrate and Installation Checklist
- When a Plan Comes Together: How Architects Improve Master Planning
- Bayer AG's SOLIDA-1 FOYA Category Award-Winning Facility
- Annex 1 and Global Harmonization on Aseptic Filling: Insights from the 2026 ISPE Aseptic Conference Regulatory Panel
- How Pharma 4.0™ Supports Inspection-Ready Compliance at the 2026 ISPE Pharma 4.0™ and Biopharma Conference
- Will EU GMP Annex 22 Include Grandfathering for Legacy Artificial Intelligence Systems? Lessons from 21 CFR Part 11
- Driving ISPE's Strategic Vision: Innovation Through Shared Ideas
- Insights from the 2026 ISPE Annual Meeting & Expo Chairs
- Manufacturing the Medicines of Tomorrow: Scaling Innovation for Patient Impact
- An Evening with the ISPE Italy Affiliate: Community and Purpose During CPHI in Milan
- Communication as Technical Infrastructure in Pharmaceutical Manufacturing
- From Digital Transformation to Human-Centric Manufacturing: Designing Collaborative Workspaces for the Future of Pharma
- The Air-Liquid Interface Is a Process Parameter
- Formulation Choices in Cannabidiol Drug Development Beyond Dispersion
- Is Process Development Really GMP?
- Inside Chugai Pharma Manufacturing’s 2026 ISPE Facility of the Year Awards (FOYA) Project: FJ3
- An Evening with the ISPE Italy Affiliate: Community and Purpose During CPHI in Milan
- From Checklist to Culture: Uniting Quality Risk Management (QRM) and Knowledge Management (KM) for Supply Reliability: A Joint Discussion on QRM and KM
- Antibody-Drug Conjugate (ADC) Cleaning Validation: How to Evaluate Degradation, Select Analytical Methods, and Reduce Validation Risk
- From Digital Transformation to Human-Centric Manufacturing: Designing Collaborative Workspaces for the Future of Pharma
- From Checklist to Culture: Uniting Quality Risk Management (QRM) and Knowledge Management (KM) for Supply Reliability: A Joint Discussion on QRM and KM
- The Second Question
- Five Questions Quality and Regulatory Teams Should Ask Before Treating a Regulatory Update as “Actionable”
- From Cloud Migration to Validated Platform Engineering: A Practical Path for GxP Systems
Explore the benefits of ISPE membership.